The Storch-Murphy Group (908) 276-0777 rmurphy@storchmurphy.com
FOR IMMEDIATE RELEASE
TERUMO MEDICAL CORPORATION ANNOUNCES FDA 510K CLEARANCE OF THE K-PACK SURSHIELDTM HYPODERMIC NEEDLE WITH INTEGRATED PASSIVE SHARPS PROTECTION
New Package Design Allows Fully Automated Secondary Packaging Of Parenteral Medication Within Optimized Space Requirements Inside The Secondary Container
BioClinica appoints Andrzej Dzik-Jurasz as its new medical director
BioClinica Appoints Senior Medical Director, Dr. Andrzej Dzik-Jurasz
New Position Expands Scientific Coverage for MRI Imaging and Oncology
NEWTOWN, Pa.–(BUSINESS WIRE)–BioClinica®, Inc. (NASDAQ: BIOC), a global provider of clinical trial management solutions, today announced the appointment of Andrzej (Andy) Dzik-Jurasz, M.D., Ph.D. as Senior Medical Director for Medical Affairs, a newly created position. Dr. Dzik-Jurasz brings more than 15 years of clinical, radiological and pharmaceutical industry experience with major pharmaceutical companies such as Novartis Pharmaceuticals and GlaxoSmithKline.
Delcath expands senior management team
NEW YORK, Sept. 26, 2011 /PRNewswire/ — Delcath Systems, Inc. (NASDAQ: DCTH) today announced the appointment of Graham G. Miao, M.S, MBA, Ph.D., 47, to the position of Executive Vice President, Chief Financial Officer (CFO). Concurrent with this appointment, David McDonald, 51, Delcath’s CFO since 2009, will assume the newly created role of Executive Vice President, Business Development. Mr. Miao will report directly to Eamonn P. Hobbs, President & CEO, and Mr. McDonald will continue to report to Mr. Hobbs. Both appointments are effective as of September 26, 2011.
Solano to leave AngioDynamics
ALBANY, N.Y.–(BUSINESS WIRE)–AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced that Scott Solano, Senior Vice President and Chief Technology Officer, has resigned his position effective October 14, 2011, to pursue other interests. Mr. Solano joined AngioDynamics in September 2010.
“We are disappointed that Scott has decided to leave AngioDynamics,” said Joseph DeVivo, President & CEO. “During the past year, Scott contributed significantly to our technology direction and product pipeline. With Scott’s full cooperation, we are implementing an orderly transition of his responsibilities.”
Accuray appoints Eric Pauwels as its senior VP and chief marketing officer
Accuray Incorporated, a medical device company, has appointed Eric Pauwels as senior vice president and chief marketing officer.
In his role, Pauwels will report to Euan Thomson, Accuray’s president and CEO, and will oversee the company’s Global Marketing Communications, Product Marketing and Patient Access functions, the company said.
Pauwels has more than 25 years of general management experience in US and European bio-pharmaceutical companies. He has successfully developed and launched more than 20 brands globally from major pharmaceuticals to highly specialized orphan drugs in the therapeutic areas of genetic diseases, cardiovascular disease, urology, gynecology, CNS/neuroscience and infectious diseases.
DHT holdings shuffles around its staff
Avedro appoints C. Evan Ballantyne as Chief Financial Officer
WALTHAM, Mass.–(BUSINESS WIRE)–Avedro, Inc., a privately held medical device and pharmaceutical company, today announced C. Evan Ballantyne as Chief Financial Officer. In this position, Mr. Ballantyne will be responsible for the Company’s financial affairs and report to David Muller, PhD, President and Chief Executive Officer. Prior to this role, Mr. Ballantyne served as Executive Vice President, Chief Financial Officer of Clinical Data, Inc., a biopharmaceutical company which was acquired in April 2011 by Forest Laboratories, Inc. for $1.3 billion.
MedAptus appoints a new Chief Medical Officer
MedAptus appoints new Chief Medical Officer.
Boston – September 28, 2011 – MedAptus®, the market leader for charge capture technologies, today announced that Ryan A. Secan, MD, MPH, has joined the company in the role of Chief Medical Officer (CMO). Dr. Secan is currently a practicing hospitalist at Emerson Hospital in Concord, Massachusetts. He was previously medical director of hospitalist programs at Lowell General Hospital Medical Group and Anna Jaques Hospital, both also located in Massachusetts.
Tengion appoints Covidien’s Flora to its board
EAST NORRITON, Pa., Sept. 28, 2011 /PRNewswire/ — Tengion, Inc. (Nasdaq: TNGN) today announced that it has appointed industry veteran Scott Flora to its Board of Directors. Mr. Flora brings to Tengion more than 20 years of experience building and managing successful wound healing and surgical device businesses. He most recently served as Global Business Unit President of Surgical Devices at Covidien.
Tengion also announced today that Gary Kurtzman, M.D., Managing Director, Life Sciences Group at Safeguard Scientifics, Inc., is stepping down from the Tengion Board of Directors after three years of service. Safeguard Scientifics was a private venture capital investor in Tengion, participating in the Company’s Series C round in November 2008.
Medtronic responds to GNOME’s Sadler
Medtronic always seeks the best available information technology solutions — open-sourced or closed-source — to serve our customers and patients. All software/firmware that resides in Medtronic devices and associated instrumentation is reviewed, approved and regulated by the FDA.
Software/firmware that runs on Medtronic devices is highly specialized to both our application as well as our unique, custom hardware platforms; to that end, it is not likely that a patient would see value in viewing software for our platforms. Furthermore,
enabling a patient to view a program code for Medtronic’s devices would require full disclosure of our proprietary hardware platforms and implementations. Security protocols and mechanisms leveraged by Medtronic’s devices and associated instrumentation
Sony enters med-tech with Micronics acquisition
Sony acquires Micronics, Inc., US diagnostic device development venture, Acquisition to accelerate development and commercialization of Point of Care diagnostic products
WEBWIRE – Wednesday, September 28, 2011